Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mitogenetics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Mitogenetics

Mitogenetics

Seed

Mitogenetics: Pioneering biomedical tech R&D, specializing in mitochondrial metabolism, since 2010.

HQ
Sioux Falls, SD, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded in 2010 and headquartered in Ames, Iowa, Mitogenetics is a research and development company dedicated to advancing biomedical technology. The company's core mission is to innovate and refine primordial energy control and signaling systems that regulate mitochondrial metabolism. By focusing on these critical areas, Mitogenetics aims to revolutionize healthcare and improve human health through cutting-edge scientific research and technological advancements.

Mitogenetics has attracted notable scientists and investors who are leaders in the field of biomedical research. The company has achieved significant milestones in understanding and manipulating mitochondrial functions, contributing to broader applications in medicine and healthcare. Through its pioneering work, Mitogenetics has made a substantial impact on the scientific community, positioning itself as a leader in the niche area of mitochondrial metabolism research.

Mitogenetics - Similar Companies

MitoLab logo

MitoLab

Mitosense logo

Mitosense

mitosenseinc.com

Mitochon Pharmaceuticals logo

Mitochon Pharmaceuticals

mitochonpharma.com

MitoStem logo

MitoStem

Continuum Biosciences logo

Continuum Biosciences

Cellvie logo

Cellvie

cellvie.bio

Capacity Bio logo

Capacity Bio

capacitybio.com

EndGenitor Technologies logo

EndGenitor Technologies

Gene Solutions logo

Gene Solutions

TriMetis Life Sciences logo

TriMetis Life Sciences

Microbiome Therapeutics logo

Microbiome Therapeutics

MitoChem Therapeutics logo

MitoChem Therapeutics

mitocheminc.com

Epigentek Group logo

Epigentek Group

epigentek.com

Metabolon logo

Metabolon

metabolon.com

Alpha Genesis logo

Alpha Genesis

Mitogenetics - Quick Facts

Who are Mitogenetics' competitors?

Companies similar to Mitogenetics include MitoLab, Mitosense, Mitochon Pharmaceuticals and MitoStem.

When was Mitogenetics founded?

Mitogenetics was founded in 2010.

Where is Mitogenetics' headquarters located?

Mitogenetics' headquarters is located in Sioux Falls, SD, US.

When was Mitogenetics' last funding round?

Mitogenetics' most recent funding round was for $2.5M (USD) in May 2016.

How much has Mitogenetics raised to-date?

As of May 2, 2016, Mitogenetics has raised a total of $4.2M (USD).

How many employees does Mitogenetics have?

Mitogenetics has 11 employees as of Feb 5, 2024.

Mitogenetics - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Biomedical Research
Tags
  • Consulting
  • Research